相似文献
1
Illusions regarding clinical trials and treatment guidelines.关于临床试验和治疗指南的错觉。
Gut. 2017 Dec;66(12):2043-2046. doi: 10.1136/gutjnl-2017-314744. Epub 2017 Sep 21.
2
Helicobacter pylori infection and antibiotic resistance: a WHO high priority?幽门螺杆菌感染和抗生素耐药性：世卫组织的高度优先事项？
Nat Rev Gastroenterol Hepatol. 2017 Jul;14(7):383-384. doi: 10.1038/nrgastro.2017.57. Epub 2017 May 3.
3
The best and worst treatments for Helicobacter pylori.幽门螺杆菌的最佳和最差治疗方法。
BMJ. 2015 Aug 19;351:h4146. doi: 10.1136/bmj.h4146.
4
How We Approach Difficult to Eradicate Helicobacter pylori.我们如何应对难以根除的幽门螺杆菌。
Gastroenterology. 2022 Jan;162(1):32-37. doi: 10.1053/j.gastro.2021.10.048. Epub 2021 Nov 3.
5
Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics.在抗生素耐药性日益增加的时代，最近的幽门螺杆菌治疗指南的协调。
Gastroenterology. 2019 Jul;157(1):44-53. doi: 10.1053/j.gastro.2019.04.011. Epub 2019 Apr 15.
6
Treatment of Helicobacter pylori infection.幽门螺杆菌感染的治疗。
BMJ. 2008 Sep 15;337:a1454. doi: 10.1136/bmj.a1454.
7
Helicobacter pylori diagnostics and treatment: could a lack of universal consensus be the best consensus?幽门螺杆菌的诊断与治疗：缺乏普遍共识会是最佳共识吗？
Clin Chem. 2014 Apr;60(4):589-94. doi: 10.1373/clinchem.2012.201475. Epub 2013 Aug 1.
8
9
Treatment of Helicobacter pylori infection: Where are we now?幽门螺杆菌感染的治疗：我们目前的进展如何？
J Gastroenterol Hepatol. 2016 Dec;31(12):1918-1926. doi: 10.1111/jgh.13418.
10
Drugs for Helicobacter pylori infection.用于幽门螺杆菌感染的药物。
Med Lett Drugs Ther. 2017 Jul 17;59(1525):113-117.
引用本文的文献
1
[Clinical and microbiological effectiveness of Helicobacter pylori eradication treatment with triple therapy].[幽门螺杆菌三联疗法根除治疗的临床及微生物学疗效]
Aten Primaria. 2025 Aug 1;57(12):103344. doi: 10.1016/j.aprim.2025.103344.
2
Crises in Antimicrobial Stewardship: Misuse of Clarithromycin for Therapy.抗菌药物管理危机：克拉霉素治疗的不当使用
Pharmacoepidemiology. 2024 Mar;3(1):82-93. doi: 10.3390/pharma3010006. Epub 2024 Feb 20.
3
Implications of the paradigm shift in management of infections.感染管理模式转变的影响
Therap Adv Gastroenterol. 2023 Mar 18;16:17562848231160858. doi: 10.1177/17562848231160858. eCollection 2023.
4
From Antibiotic Resistance to Antibiotic Renaissance: A New Era in Helicobacter pylori Treatment.从抗生素耐药到抗生素复兴：幽门螺杆菌治疗的新时代
Cureus. 2023 Mar 12;15(3):e36041. doi: 10.7759/cureus.36041. eCollection 2023 Mar.
5
A Simplified Low-Dose 10-Day Quadruple Therapy with a Galenic Formulation of Bismuth Salicylate Is Highly Effective for Eradication.一种含碱式水杨酸铋的盖伦制剂简化低剂量10日四联疗法根除幽门螺杆菌疗效显著。
J Clin Med. 2023 Jan 15;12(2):681. doi: 10.3390/jcm12020681.
6
How widespread and convenient susceptibility testing will result in pharmacological opportunities.药敏试验的广泛应用和便利性将带来药理学机遇。
Expert Rev Gastroenterol Hepatol. 2023 Jan;17(1):1-7. doi: 10.1080/17474124.2023.2162502. Epub 2023 Jan 4.
7
Prevalence of antibiotic resistance of isolates in Shanghai, China.中国上海分离株的抗生素耐药性患病率。
Am J Transl Res. 2022 Nov 15;14(11):7831-7841. eCollection 2022.
8
diagnosis and therapy in the era of antimicrobial stewardship.抗菌药物管理时代的诊断与治疗
Therap Adv Gastroenterol. 2021 Dec 21;14:17562848211064080. doi: 10.1177/17562848211064080. eCollection 2021.
9
Transitioning of Therapy from Trial and Error to Antimicrobial Stewardship.治疗从试错法向抗菌药物管理的转变。
Antibiotics (Basel). 2020 Oct 3;9(10):671. doi: 10.3390/antibiotics9100671.
10
Characteristics of antibiotic resistance: data from four different populations.抗生素耐药性特征：来自四个不同人群的数据。
Antimicrob Resist Infect Control. 2019 Nov 27;8:192. doi: 10.1186/s13756-019-0632-1. eCollection 2019.
本文引用的文献
1
It is time to rethink H. pylori therapy.是时候重新思考幽门螺杆菌的治疗方法了。
J Gastrointestin Liver Dis. 2017 Jun;26(2):115-117. doi: 10.15403/jgld.2014.1121.262.hpy.
2
Twelve-day quintuple regime containing four antibiotics as a rescue therapy for Helicobacter pylori eradication in the central region of Portugal.含四种抗生素的十二天五联疗法作为葡萄牙中部地区根除幽门螺杆菌的挽救治疗方案。
Rev Esp Enferm Dig. 2017 Jun;109(6):430-434. doi: 10.17235/reed.2017.4759/2016.
3
Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication.系统评价与荟萃分析：基于沃克奥美拉唑的三联疗法对幽门螺杆菌根除的疗效
Aliment Pharmacol Ther. 2017 Jul;46(2):106-114. doi: 10.1111/apt.14130. Epub 2017 May 12.
4
Helicobacter pylori infection and antibiotic resistance: a WHO high priority?幽门螺杆菌感染和抗生素耐药性：世卫组织的高度优先事项？
Nat Rev Gastroenterol Hepatol. 2017 Jul;14(7):383-384. doi: 10.1038/nrgastro.2017.57. Epub 2017 May 3.
5
Treating Helicobacter pylori effectively while minimizing misuse of antibiotics.有效治疗幽门螺杆菌，同时最大限度减少抗生素滥用。
Cleve Clin J Med. 2017 Apr;84(4):310-318. doi: 10.3949/ccjm.84a.14110.
6
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.美国胃肠病学会临床指南：幽门螺杆菌感染的治疗
Am J Gastroenterol. 2017 Feb;112(2):212-239. doi: 10.1038/ajg.2016.563. Epub 2017 Jan 10.
7
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.幽门螺杆菌感染的管理——马斯特里赫特 V/佛罗伦萨共识报告。
Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.
8
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.《多伦多成人幽门螺杆菌感染治疗共识》。
Gastroenterology. 2016 Jul;151(1):51-69.e14. doi: 10.1053/j.gastro.2016.04.006. Epub 2016 Apr 19.
9
Helicobacter pylori therapy: a paradigm shift.幽门螺杆菌治疗：范式转变。
Expert Rev Anti Infect Ther. 2016 Jun;14(6):577-85. doi: 10.1080/14787210.2016.1178065. Epub 2016 May 3.
10
Vonoprazan Helicobacter pylori eradication therapy: ethical and interpretation issues.沃克帕唑根除幽门螺杆菌治疗：伦理与解读问题。
Gut. 2017 Feb;66(2):384-386. doi: 10.1136/gutjnl-2016-311796. Epub 2016 Apr 7.
Zotero 插件